市場調查報告書

視網膜疾病治療市場 - 全球產業分析,規模,佔有率,成長,趨勢,預測

Retinal Disorder Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027

出版商 Transparency Market Research 商品編碼 926757
出版日期 內容資訊 英文 225 Pages
商品交期: 最快1-2個工作天內
價格
視網膜疾病治療市場 - 全球產業分析,規模,佔有率,成長,趨勢,預測 Retinal Disorder Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027
出版日期: 2020年01月22日內容資訊: 英文 225 Pages
簡介

本報告提供全球視網膜疾病治療市場相關調查,彙整市場趨勢與預測,市場規模,主要加入企業,各地區趨勢相關資訊。

第1章 序論

第2章 假設和調查方法

第3章 摘要整理

第4章 市場概要

  • 產品概要
  • 主要的產業活動
  • 市場趨勢
    • 促進要素
    • 阻礙要素
    • 機會
  • 市場收益預測
  • 市場預測

第5章 市場預測

  • 臨床實驗分析
  • 法律規章方案
  • 開發平台分析
  • 主要的合併·收購
  • 償付方案

第6章 市場分析:各疾病適應症

  • 簡介
  • 市場值佔有率與魅力度分析
  • 市場預測
    • 黃斑部病變
    • 糖尿病視網膜病變
    • 糖尿病黃斑部水腫
    • 其他

第7章 市場分析:各治療水準

  • 簡介
  • 市場值佔有率與魅力度分析
  • 市場預測
    • 抗VEGF劑
    • 其他

第8章 市場分析:各劑型

  • 簡介
  • 市場值佔有率與魅力度分析
  • 市場預測
    • 凝膠
    • 眼科用液劑
    • 膠囊,錠劑
    • 眼科用藥
    • 軟膏
  • 市場分析

第9章 市場分析:各流通管道

  • 簡介
  • 市場值佔有率與魅力度分析
  • 市場預測
    • 院內藥局
    • 零售藥局
    • 線上銷售
  • 市場分析

第10章 市場分析:各地區

  • 各國市場方案
  • 市場值佔有率與魅力度分析
  • 市場預測
    • 北美
    • 歐洲
    • 亞太地區
    • 南美
    • 中東·非洲

第11章 北美

第12章 歐洲

第13章 亞太地區

第14章 南美

第15章 中東·非洲

第16章 競爭環境

  • 市場佔有率分析
  • 競爭矩陣
  • 企業簡介
目錄
Product Code: TMRGL74161

Title:
Retinal Disorder Treatment Market (Disease Indication: Macular Degeneration, Diabetic Retinopathy, Diabetic Macular Edema, and Others; Therapeutic Class: Anti-VEGF Agents and Others (Anti-inflammatory Drugs, etc.); Dosage Form: Gels, Eye Solutions, Capsules & Tablets, Eye Drops, and Ointments; and Distribution Channel: Hospital Pharmacies, Retail Pharmacies, and Online Sales) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027.

Retinal Disorder Treatment Market - Scope of the Report

TMR's report on the global retinal disorder treatment market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators for the market during the forecast period from 2019 to 2027. The report provides revenue of the retinal disorder treatment market for the period 2017-2027, considering 2018 as the base year and 2027 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the retinal disorder treatment market from 2019 to 2027.

The report is prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Extensive secondary research involved reaching out to key players' product literature, annual reports, press releases, and relevant documents to understand the retinal disorder treatment market.

Secondary research also includes Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the retinal disorder treatment market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments and sub-segments included in the scope of the study. Moreover, the report sheds light on changing competitive dynamics in the retinal disorder treatment market. These serve as valuable tools for existing market players as well as for entities interested in participating in the retinal disorder treatment market.

The report delves into the competitive landscape of the retinal disorder treatment market. Key players operating in the retinal disorder treatment market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the retinal disorder treatment market that are profiled in this report.

Key Questions Answered in TMR's Report on Retinal Disorder Treatment Market

What is the sales/revenue generated by retinal disorder treatment products across all regions during the forecast period?

What are the opportunities in the retinal disorder treatment market?

What are the major drivers, restraints, opportunities, and threats in the market?

In which region is the retinal disorder treatment market set to expand at the fastest CAGR during the forecast period?

Which product segment is expected to generate the highest revenue globally in 2027? Which segment is projected to expand at the highest CAGR during the forecast period?

What are the market positions of different companies operating in the global market?

Retinal Disorder Treatment Market - Research Objectives and Research Approach

The comprehensive report on the retinal disorder treatment market begins with an overview, followed by the scope and objectives of the study. Following this, the report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller sections. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the retinal disorder treatment market, in terms of disease indication, therapeutic class, dosage form, distribution channel, and region. Key segments under each criteria have been studied at length, and the market share for each of these at the end of 2027 has also been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the retinal disorder treatment market.

Table of Contents

1. Preface

  • 1.1. Report Scope and Market Segmentation
  • 1.2. Research Highlights

2. Assumptions and Research Methodology

  • 2.1. Assumptions
  • 2.2. Research Methodology

3. Executive Summary

  • 3.1. Global Retinal Disorder Treatment Market Snapshot

4. Market Overview

  • 4.1. Product Overview
  • 4.2. Key Industry Events
  • 4.3. Market Dynamics
    • 4.3.1. Drivers and Restraints Snapshot Analysis
    • 4.3.2. Drivers
    • 4.3.3. Restraints
    • 4.3.4. Opportunities
  • 4.4. Global Retinal Disorder Treatment Market Revenue Projection
  • 4.5. Global Retinal Disorder Treatment Market Outlook

5. Market Outlook

  • 5.1. Clinical Trial Analysis
  • 5.2. Regulatory Scenario
  • 5.3. Pipeline Analysis
  • 5.4. Key Mergers & Acquisitions
  • 5.5. Reimbursement Scenario

6. Global Retinal Disorder Treatment Market Analysis, by Disease Indication

  • 6.1. Introduction
  • 6.2. Global Retinal Disorder Treatment Market Value Share and Attractiveness Analysis, by Disease Indication
  • 6.3. Global Retinal Disorder Treatment Market Forecast, by Disease Indication
    • 6.3.1. Macular Degeneration
      • 6.3.1.1. Dry Macular Degeneration
      • 6.3.1.2. Wet Macular Degeneration
    • 6.3.2. Diabetic Retinopathy
    • 6.3.3. Diabetic Macular Edema
    • 6.3.4. Others (Retinal Vein Occlusion, etc.)

7. Global Retinal Disorder Treatment Market Analysis, by Therapeutic Class

  • 7.1. Introduction
  • 7.2. North America Retinal Disorder Treatment Market Value Share and Attractiveness Analysis, by Therapeutic Class
  • 7.3. North America Retinal Disorder Treatment Market Forecast, by Therapeutic Class
    • 7.3.1. Anti-VEGF Agents
    • 7.3.2. Others (Anti-inflammatory Drugs, etc.)

8. Global Retinal Disorder Treatment Market Analysis, by Dosage Form

  • 8.1. Introduction
  • 8.2. Global Retinal Disorder Treatment Market Value Share and Attractiveness Analysis, by Dosage Form
  • 8.3. Global Retinal Disorder Treatment Market Forecast, by Dosage Form
    • 8.3.1. Gels
    • 8.3.2. Eye Solutions
    • 8.3.3. Capsules & Tablets
    • 8.3.4. Eye Drops
    • 8.3.5. Ointments
  • 8.4. Global Retinal Disorder Treatment Market Analysis, by Dosage Form

9. Global Retinal Disorder Treatment Market Analysis, by Distribution Channel

  • 9.1. Introduction
  • 9.2. Global Retinal Disorder Treatment Market Value Share and Attractiveness Analysis, by Distribution Channel
  • 9.3. Global Retinal Disorder Treatment Market Forecast, by Distribution Channel
    • 9.3.1. Hospital Pharmacies
    • 9.3.2. Retail Pharmacies
    • 9.3.3. Online Sales
  • 9.4. Global Retinal Disorder Treatment Market Analysis, by Distribution Channel

10. Global Retinal Disorder Treatment Market Analysis, by Region

  • 10.1. Global Retinal Disorder Treatment Market Scenario, by Country
  • 10.2. Global Retinal Disorder Treatment Market Value Share and Attractiveness Analysis, by Region
  • 10.3. Global Retinal Disorder Treatment Market Forecast, by Region
    • 10.3.1. North America
    • 10.3.2. Europe
    • 10.3.3. Asia Pacific
    • 10.3.4. Latin America
    • 10.3.5. Middle East & Africa

11. North America Retinal Disorder Treatment Market Analysis

  • 11.1. Key Findings
  • 11.2. North America Retinal Disorder Treatment Market Overview
  • 11.3. North America Retinal Disorder Treatment Market Value Share and Attractiveness Analysis, by Country
  • 11.4. North America Retinal Disorder Treatment Market Forecast, by Country
    • 11.4.1. U.S.
    • 11.4.2. Canada
  • 11.5. North America Retinal Disorder Treatment Market Value Share and Attractiveness Analysis, by Disease Indication
  • 11.6. North America Retinal Disorder Treatment Market Forecast, by Disease Indication
    • 11.6.1. Macular Degeneration
      • 11.6.1.1. Dry Macular Degeneration
      • 11.6.1.2. Wet Macular Degeneration
    • 11.6.2. Diabetic Retinopathy
    • 11.6.3. Diabetic Macular Edema
    • 11.6.4. Others (Retinal Vein Occlusion, etc.)
  • 11.7. North America Retinal Disorder Treatment Market Value Share and Attractiveness Analysis, by Therapeutic Class
  • 11.8. North America Retinal Disorder Treatment Market Forecast, by Therapeutic Class
    • 11.8.1. Anti-VEGF Agents
    • 11.8.2. Others (Anti-inflammatory Drugs, etc.)
  • 11.9. North America Retinal Disorder Treatment Market Value Share and Attractiveness Analysis, by Dosage Form
  • 11.10. North America Retinal Disorder Treatment Market Forecast, by Dosage Form
    • 11.10.1. Gels
    • 11.10.2. Eye Solutions
    • 11.10.3. Capsules & Tablets
    • 11.10.4. Eye Drops
    • 11.10.5. Ointments
  • 11.11. North America Retinal Disorder Treatment Market Value Share and Attractiveness Analysis, by Distribution Channel
  • 11.12. North America Retinal Disorder Treatment Market Forecast, by Distribution Channel
    • 11.12.1. Hospital Pharmacies
    • 11.12.2. Retail Pharmacies
    • 11.12.3. Online Sales

12. Europe Retinal Disorder Treatment Market Analysis

  • 12.1. Key Findings
  • 12.2. Europe Retinal Disorder Treatment Market Overview
  • 12.3. Europe Retinal Disorder Treatment Market Value Share and Attractiveness Analysis, by Country/Sub-region
  • 12.4. Europe Retinal Disorder Treatment Market Forecast, by Country/Sub-region
    • 12.4.1. Germany
    • 12.4.2. France
    • 12.4.3. U.K.
    • 12.4.4. Italy
    • 12.4.5. Spain
    • 12.4.6. Rest of Europe
  • 12.5. Europe Retinal Disorder Treatment Market Value Share and Attractiveness Analysis, by Disease Indication
  • 12.6. Europe Retinal Disorder Treatment Market Forecast, by Disease Indication
    • 12.6.1. Macular Degeneration
      • 12.6.1.1. Dry Macular Degeneration
      • 12.6.1.2. Wet Macular Degeneration
    • 12.6.2. Diabetic Retinopathy
    • 12.6.3. Diabetic Macular Edema
    • 12.6.4. Others (Retinal Vein Occlusion, etc.)
  • 12.7. Europe Retinal Disorder Treatment Market Value Share and Attractiveness Analysis, by Therapeutic Class
  • 12.8. Europe Retinal Disorder Treatment Market Forecast, by Therapeutic Class
    • 12.8.1. Anti-VEGF Agents
    • 12.8.2. Others (Anti-inflammatory Drugs, etc.)
  • 12.9. Europe Retinal Disorder Treatment Market Value Share and Attractiveness Analysis, by Dosage Form
  • 12.10. Europe Retinal Disorder Treatment Market Forecast, by Dosage Form
    • 12.10.1. Gels
    • 12.10.2. Eye Solutions
    • 12.10.3. Capsules & Tablets
    • 12.10.4. Eye Drops
    • 12.10.5. Ointments
  • 12.11. Europe Retinal Disorder Treatment Market Value Share and Attractiveness Analysis, by Distribution Channel
  • 12.12. Europe Retinal Disorder Treatment Market Forecast, by Distribution Channel
    • 12.12.1. Hospital Pharmacies
    • 12.12.2. Retail Pharmacies
    • 12.12.3. Online Sales

13. Asia Pacific Retinal Disorder Treatment Market Analysis

  • 13.1. Key Findings
  • 13.2. Asia Pacific Retinal Disorder Treatment Market Overview
  • 13.3. Asia Pacific Retinal Disorder Treatment Market Value Share and Attractiveness Analysis, by Country/Sub-region
  • 13.4. Asia Pacific Retinal Disorder Treatment Market Forecast, by Country/Sub-region
    • 13.4.1. Japan
    • 13.4.2. China
    • 13.4.3. India
    • 13.4.4. Australia & New Zealand
    • 13.4.5. Rest of Asia Pacific
  • 13.5. Asia Pacific Retinal Disorder Treatment Market Value Share and Attractiveness Analysis, by Disease Indication
  • 13.6. Asia Pacific Retinal Disorder Treatment Market Forecast, by Disease Indication
    • 13.6.1. Macular Degeneration
      • 13.6.1.1. Dry Macular Degeneration
      • 13.6.1.2. Wet Macular Degeneration
    • 13.6.2. Diabetic Retinopathy
    • 13.6.3. Diabetic Macular Edema
    • 13.6.4. Others (Retinal Vein Occlusion, etc.)
  • 13.7. Asia Pacific Retinal Disorder Treatment Market Value Share and Attractiveness Analysis, by Therapeutic Class
  • 13.8. Asia Pacific Retinal Disorder Treatment Market Forecast, by Therapeutic Class
    • 13.8.1. Anti-VEGF Agents
    • 13.8.2. Others (Anti-inflammatory Drugs, etc.)
  • 13.9. Asia Pacific Retinal Disorder Treatment Market Value Share and Attractiveness Analysis, by Dosage Form
  • 13.10. Asia Pacific Retinal Disorder Treatment Market Forecast, by Dosage Form
    • 13.10.1. Gels
    • 13.10.2. Eye Solutions
    • 13.10.3. Capsules & Tablets
    • 13.10.4. Eye Drops
    • 13.10.5. Ointments
  • 13.11. Asia Pacific Retinal Disorder Treatment Market Value Share and Attractiveness Analysis, by Distribution Channel
  • 13.12. Asia Pacific Retinal Disorder Treatment Market Forecast, by Distribution Channel
    • 13.12.1. Hospital Pharmacies
    • 13.12.2. Retail Pharmacies
    • 13.12.3. Online Sales

14. Latin America Retinal Disorder Treatment Market Analysis

  • 14.1. Key Findings
  • 14.2. Latin America Retinal Disorder Treatment Market Overview
  • 14.3. Latin America Retinal Disorder Treatment Market Value Share and Attractiveness Analysis, by Country/Sub-region
  • 14.4. Latin America Retinal Disorder Treatment Market Forecast, by Country/Sub-region
    • 14.4.1. Brazil
    • 14.4.2. Mexico
    • 14.4.3. Rest of Latin America
  • 14.5. Latin America Retinal Disorder Treatment Market Value Share and Attractiveness Analysis, by Disease Indication
  • 14.6. Latin America Retinal Disorder Treatment Market Forecast, by Disease Indication
    • 14.6.1. Macular Degeneration
      • 14.6.1.1. Dry Macular Degeneration
      • 14.6.1.2. Wet Macular Degeneration
    • 14.6.2. Diabetic Retinopathy
    • 14.6.3. Diabetic Macular Edema
    • 14.6.4. Others (Retinal Vein Occlusion, etc.)
  • 14.7. Latin America Retinal Disorder Treatment Market Value Share and Attractiveness Analysis, by Therapeutic Class
  • 14.8. Latin America Retinal Disorder Treatment Market Forecast, by Therapeutic Class
    • 14.8.1. Anti-VEGF Agents
    • 14.8.2. Others (Anti-inflammatory Drugs, etc.)
  • 14.9. Latin America Retinal Disorder Treatment Market Value Share and Attractiveness Analysis, by Dosage Form
  • 14.10. Latin America Retinal Disorder Treatment Market Forecast, by Dosage Form
    • 14.10.1. Gels
    • 14.10.2. Eye Solutions
    • 14.10.3. Capsules & Tablets
    • 14.10.4. Eye Drops
    • 14.10.5. Ointments
  • 14.11. Latin America Retinal Disorder Treatment Market Value Share and Attractiveness Analysis, by Distribution Channel
  • 14.12. Latin America Retinal Disorder Treatment Market Forecast, by Distribution Channel
    • 14.12.1. Hospital Pharmacies
    • 14.12.2. Retail Pharmacies
    • 14.12.3. Online Sales

15. Middle East & Africa Retinal Disorder Treatment Market Analysis

  • 15.1. Key Findings
  • 15.2. Middle East & Africa Retinal Disorder Treatment Market Overview
  • 15.3. Middle East & Africa Retinal Disorder Treatment Market Value Share and Attractiveness Analysis, by Country/Sub-region
  • 15.4. Middle East & Africa Retinal Disorder Treatment Market Forecast, by Country/Sub-region
    • 15.4.1. GCC Countries
    • 15.4.2. South Africa
    • 15.4.3. Rest of Middle East & Africa
  • 15.5. Middle East & Africa Retinal Disorder Treatment Market Value Share and Attractiveness Analysis, by Disease Indication
  • 15.6. Middle East & Africa Retinal Disorder Treatment Market Forecast, by Disease Indication
    • 15.6.1. Macular Degeneration
      • 15.6.1.1. Dry Macular Degeneration
      • 15.6.1.2. Wet Macular Degeneration
    • 15.6.2. Diabetic Retinopathy
    • 15.6.3. Diabetic Macular Edema
    • 15.6.4. Others (Retinal Vein Occlusion, etc.)
  • 15.7. Middle East & Africa Retinal Disorder Treatment Market Value Share and Attractiveness Analysis, by Therapeutic Class
  • 15.8. Middle East & Africa Retinal Disorder Treatment Market Forecast, by Therapeutic Class
    • 15.8.1. Anti-VEGF Agents
    • 15.8.2. Others (Anti-inflammatory Drugs, etc.)
  • 15.9. Middle East & Africa Retinal Disorder Treatment Market Value Share and Attractiveness Analysis, by Dosage Form
  • 15.10. Middle East & Africa Retinal Disorder Treatment Market Forecast, by Dosage Form
    • 15.10.1. Gels
    • 15.10.2. Eye Solutions
    • 15.10.3. Capsules & Tablets
    • 15.10.4. Eye Drops
    • 15.10.5. Ointments
  • 15.11. Middle East & Africa Retinal Disorder Treatment Market Value Share and Attractiveness Analysis, by Distribution Channel
  • 15.12. Middle East & Africa Retinal Disorder Treatment Market Forecast, by Distribution Channel
    • 15.12.1. Hospital Pharmacies
    • 15.12.2. Retail Pharmacies
    • 15.12.3. Online Sales

16. Competition Analysis

  • 16.1. Global Retinal Disorder Treatment Market Share Analysis, by Company
  • 16.2. Competition Matrix
  • 16.3. Company Profile
    • 16.3.1. Santen Pharmaceutical Co., Ltd.
      • 16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.1.2. Financial Overview
      • 16.3.1.3. Product Portfolio
      • 16.3.1.4. SWOT Analysis
      • 16.3.1.5. Strategic Overview
    • 16.3.2. Regeneron Pharmaceuticals, Inc.
      • 16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.2.2. Financial Overview
      • 16.3.2.3. Product Portfolio
      • 16.3.2.4. SWOT Analysis
      • 16.3.2.5. Strategic Overview
    • 16.3.3. F. Hoffmann-La Roche Ltd.
      • 16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.3.2. Financial Overview
      • 16.3.3.3. Product Portfolio
      • 16.3.3.4. SWOT Analysis
      • 16.3.3.5. Strategic Overview
    • 16.3.4. Pfizer, Inc.
      • 16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.4.2. Financial Overview
      • 16.3.4.3. Product Portfolio
      • 16.3.4.4. SWOT Analysis
      • 16.3.4.5. Strategic Overview
    • 16.3.5. Allergan plc
      • 16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.5.2. Financial Overview
      • 16.3.5.3. Product Portfolio
      • 16.3.5.4. SWOT Analysis
      • 16.3.5.5. Strategic Overview
    • 16.3.6. Shire (Takeda Pharmaceutical Company Limited)
      • 16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.6.2. Financial Overview
      • 16.3.6.3. Product Portfolio
      • 16.3.6.4. SWOT Analysis
      • 16.3.6.5. Strategic Overview
    • 16.3.7. Bayer AG
      • 16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.7.2. Financial Overview
      • 16.3.7.3. Product Portfolio
      • 16.3.7.4. SWOT Analysis
      • 16.3.7.5. Strategic Overview
    • 16.3.8. Graybug Vision, Inc.
      • 16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.8.2. Financial Overview
      • 16.3.8.3. Product Portfolio
      • 16.3.8.4. SWOT Analysis
      • 16.3.8.5. Strategic Overview
    • 16.3.9. Novartis AG
      • 16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.9.2. Financial Overview
      • 16.3.9.3. Product Portfolio
      • 16.3.9.4. SWOT Analysis
      • 16.3.9.5. Strategic Overview
    • 16.3.10. Acucela Inc. (Kubota Pharmaceutical Holdings Co., Ltd.)
      • 16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.10.2. Financial Overview
      • 16.3.10.3. Product Portfolio
      • 16.3.10.4. SWOT Analysis
      • 16.3.10.5. Strategic Overview

List of Tables

  • Table 01: Global Retinal Disorder Treatment Market Value (US$ Mn) Forecast, by Disease Indication, 2017-2027
  • Table 02: Global Retinal Disorder Treatment Market Value (US$ Mn) Forecast, by Macular Degeneration, 2017-2027
  • Table 03: North America Retinal Disorder Treatment Market Value (US$ Mn) Forecast, by Therapeutic Class, 2017-2027
  • Table 04: Global Retinal Disorder Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2027
  • Table 05: Global Retinal Disorder Treatment Market Value (US$ Mn) Forecast, by Region, 2017-2027
  • Table 06: North America Retinal Disorder Treatment Market Value (US$ Mn) Forecast, by Country, 2017-2027
  • Table 07: North America Retinal Disorder Treatment Market Value (US$ Mn) Forecast, by Disease Indication, 2017-2027
  • Table 08: North America Retinal Disorder Treatment Market Value (US$ Mn) Forecast, by Macular Degeneration, 2017-2027
  • Table 09: North America Retinal Disorder Treatment Market Value (US$ Mn) Forecast, by Therapeutic Class, 2017-2027
  • Table 10: North America Retinal Disorder Treatment Market Value (US$ Mn) Forecast, by Dosage Form, 2017-2027
  • Table 11: North America Retinal Disorder Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2027
  • Table 12: Europe Retinal Disorder Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027
  • Table 13: Europe Retinal Disorder Treatment Market Value (US$ Mn) Forecast, by Disease Indication, 2017-2027
  • Table 14: Europe Retinal Disorder Treatment Market Value (US$ Mn) Forecast, by Macular Degeneration, 2017-2027
  • Table 15: Europe Retinal Disorder Treatment Market Value (US$ Mn) Forecast, by Therapeutic Class, 2017-2027
  • Table 16: Europe Retinal Disorder Treatment Market Value (US$ Mn) Forecast, by Dosage Form, 2017-2027
  • Table 17: Europe Retinal Disorder Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2027
  • Table 18: Asia Pacific Retinal Disorder Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027
  • Table 19: Asia Pacific Retinal Disorder Treatment Market Value (US$ Mn) Forecast, by Disease Indication, 2017-2027
  • Table 20: Asia Pacific Retinal Disorder Treatment Market Value (US$ Mn) Forecast, by Macular Degeneration, 2017-2027
  • Table 21: Asia Pacific Retinal Disorder Treatment Market Value (US$ Mn) Forecast, by Therapeutic Class, 2017-2027
  • Table 22: Asia Pacific Retinal Disorder Treatment Market Value (US$ Mn) Forecast, by Dosage Form, 2017-2027
  • Table 23: Asia Pacific Retinal Disorder Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2027
  • Table 24: Latin America Retinal Disorder Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027
  • Table 25: Latin America Retinal Disorder Treatment Market Value (US$ Mn) Forecast, by Disease Indication, 2017-2027
  • Table 26: Latin America Retinal Disorder Treatment Market Value (US$ Mn) Forecast, by Macular Degeneration, 2017-2027
  • Table 27: Latin America Retinal Disorder Treatment Market Value (US$ Mn) Forecast, by Therapeutic Class, 2017-2027
  • Table 28: Latin America Retinal Disorder Treatment Market Value (US$ Mn) Forecast, by Dosage Form, 2017-2027
  • Table 29: Latin America Retinal Disorder Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2027
  • Table 30: Middle East & Africa Retinal Disorder Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027
  • Table 31: Middle East & Africa Retinal Disorder Treatment Market Value (US$ Mn) Forecast, by Disease Indication, 2017-2027
  • Table 32: Middle East & Africa Retinal Disorder Treatment Market Value (US$ Mn) Forecast, by Macular Degeneration, 2017-2027
  • Table 33: Middle East & Africa Retinal Disorder Treatment Market Value (US$ Mn) Forecast, by Therapeutic Class, 2017-2027
  • Table 34: Middle East & Africa Retinal Disorder Treatment Market Value (US$ Mn) Forecast, by Dosage Form, 2017-2027
  • Table 35: Middle East & Africa Retinal Disorder Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2027

List of Figures

  • Figure 01: Global retinal disorder treatment Market Value (US$ Mn) and Distribution (%), by Region, 2018 and 2027
  • Figure 02: Global Retinal Disorder Treatment Market Value (US$ Mn) and Forecast, 2019-2027
  • Figure 03: Global Retinal Disorder Treatment Market Value Share (%), by Disease Indication, 2018
  • Figure 04: Global Retinal Disorder Treatment Market Value Share (%), by Therapeutic Class, 2018
  • Figure 05: Global Retinal Disorder Treatment Market Value Share (%), by Dosage Form, 2018
  • Figure 06: Global Retinal Disorder Treatment Market Value Share (%), by Region, 2018
  • Figure 07: Global Retinal Disorder Treatment Market Value Share (%), by Distribution Channel, 2018
  • Figure 08: Clinical Trial Analysis by Phase
  • Figure 09: Clinical Trial Analysis by Status
  • Figure 10: Clinical Trial Analysis by Completion and Termination Rate
  • Figure 11: Clinical Trial Analysis by Region
  • Figure 12: Global Retinal Disorder Treatment Market Value Share Analysis, by Disease Indication, 2018 and 2027
  • Figure 13: Global Retinal Disorder Treatment Market Attractiveness, by Disease Indication, 2019-2027
  • Figure 14: Global Retinal Disorder Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Macular Degeneration, 2017-2027
  • Figure 15: Global Retinal Disorder Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Diabetes Retinopathy, 2017-2027
  • Figure 16: Global Retinal Disorder Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Diabetic Macular Edema, 2017-2027
  • Figure 17: Global Retinal Disorder Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others (Retinal Vein Occlusion, etc.), 2017-2027
  • Figure 18: North America Retinal Disorder Treatment Market Value Share Analysis, by Therapeutic Class, 2018 and 2027
  • Figure 19: North America Retinal Disorder Treatment Market Attractiveness, by Therapeutic Class, 2019-2027
  • Figure 20: Global Retinal Disorder Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Anti-VEGF Agents, 2017-2027
  • Figure 21: Global Retinal Disorder Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others (Anti-inflammatory Drugs, etc.), 2017-2027
  • Figure 22: Global Retinal Disorder Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Gels, 2017-2027
  • Figure 23: Global Retinal Disorder Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Eye Solutions, 2017-2027
  • Figure 24: Global Retinal Disorder Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Capsules & Tablets, 2017-2027
  • Figure 25: Global Retinal Disorder Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Eye Drops, 2017-2027
  • Figure 26: Global Retinal Disorder Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Ointments, 2017-2027
  • Figure 27: Global Retinal Disorder Treatment Market Value Share, by Distribution Channel, 2018 and 2027
  • Figure 28: Global Retinal Disorder Treatment Market Attractiveness, by Distribution Channel, 2019-2027
  • Figure 29: Global Retinal Disorder Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hospital Pharmacies, 2017-2027
  • Figure 30: Global Retinal Disorder Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Retail Pharmacies, 2017-2027
  • Figure 31: Global Retinal Disorder Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Online Sales, 2017-2027
  • Figure 32: Global Retinal Disorder Treatment Market Value Share, by Region, 2018 and 2027
  • Figure 33: Global Retinal Disorder Treatment Market Attractiveness, by Region, 2019-2027
  • Figure 34: North America Retinal Disorder Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2027
  • Figure 35: North America Retinal Disorder Treatment Market Value Share Analysis, by Country, 2018 and 2027
  • Figure 36: North America Retinal Disorder Treatment Market Attractiveness, by Country, 2019-2027
  • Figure 37: North America Retinal Disorder Treatment Market Value Share Analysis, by Disease Indication, 2018 and 2027
  • Figure 38: North America Retinal Disorder Treatment Market Attractiveness, by Disease Indication, 2019-2027
  • Figure 39: North America Retinal Disorder Treatment Market Value Share Analysis, by Therapeutic Class, 2018 and 2027
  • Figure 40: North America Retinal Disorder Treatment Market Attractiveness, by Therapeutic Class, 2019-2027
  • Figure 41: North America Retinal Disorder Treatment Market Value Share, by Dosage Form, 2018 and 2027
  • Figure 42: North America Retinal Disorder Treatment Market Attractiveness, by Dosage Form, 2019-2027
  • Figure 43: North America Retinal Disorder Treatment Market Value Share, by Distribution Channel, 2018 and 2027
  • Figure 44: North America Retinal Disorder Treatment Market Attractiveness, by Distribution Channel, 2019-2027
  • Figure 45: Europe Retinal Disorder Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2027
  • Figure 46: Europe Retinal Disorder Treatment Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
  • Figure 47: Europe Retinal Disorder Treatment Market Attractiveness, by Country/Sub-region, 2019-2027
  • Figure 48: Europe Retinal Disorder Treatment Market Value Share Analysis, by Disease Indication, 2018 and 2027
  • Figure 49: Europe Retinal Disorder Treatment Market Attractiveness, by Disease Indication, 2019-2027
  • Figure 50: Europe Retinal Disorder Treatment Market Value Share Analysis, by Therapeutic Class, 2018 and 2027
  • Figure 51: Europe Retinal Disorder Treatment Market Attractiveness, by Therapeutic Class, 2019-2027
  • Figure 52: Europe Retinal Disorder Treatment Market Value Share, by Dosage Form, 2018 and 2027
  • Figure 53: Europe Retinal Disorder Treatment Market Attractiveness, by Dosage Form, 2019-2027
  • Figure 54: Europe Retinal Disorder Treatment Market Value Share, by Distribution Channel, 2018 and 2027
  • Figure 55: Europe Retinal Disorder Treatment Market Attractiveness, by Distribution Channel, 2019-2027
  • Figure 56: Asia Pacific Retinal Disorder Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2027
  • Figure 57: Asia Pacific Retinal Disorder Treatment Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
  • Figure 58: Asia Pacific Retinal Disorder Treatment Market Attractiveness, by Country/Sub-region, 2019-2027
  • Figure 59: Asia Pacific Retinal Disorder Treatment Market Value Share Analysis, by Disease Indication, 2018 and 2027
  • Figure 60: Asia Pacific Retinal Disorder Treatment Market Attractiveness, by Disease Indication, 2019-2027
  • Figure 61: Asia Pacific Retinal Disorder Treatment Market Value Share Analysis, by Therapeutic Class, 2018 and 2027
  • Figure 62: Asia Pacific Retinal Disorder Treatment Market Attractiveness, by Therapeutic Class, 2019-2027
  • Figure 63: Asia Pacific Retinal Disorder Treatment Market Value Share, by Dosage Form, 2018 and 2027
  • Figure 64: Asia Pacific Retinal Disorder Treatment Market Attractiveness, by Dosage Form, 2019-2027
  • Figure 65: Asia Pacific Retinal Disorder Treatment Market Value Share, by Distribution Channel, 2018 and 2027
  • Figure 66: Asia Pacific Retinal Disorder Treatment Market Attractiveness, by Distribution Channel, 2019-2027
  • Figure 67: Latin America Retinal Disorder Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2027
  • Figure 68: Latin America Retinal Disorder Treatment Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
  • Figure 69: Latin America Retinal Disorder Treatment Market Attractiveness, by Country/Sub-region, 2019-2027
  • Figure 70: Latin America Retinal Disorder Treatment Market Value Share Analysis, by Disease Indication, 2018 and 2027
  • Figure 71: Latin America Retinal Disorder Treatment Market Attractiveness, by Disease Indication, 2019-2027
  • Figure 72: Latin America Retinal Disorder Treatment Market Value Share Analysis, by Therapeutic Class, 2018 and 2027
  • Figure 73: Latin America Retinal Disorder Treatment Market Attractiveness, by Therapeutic Class, 2019-2027
  • Figure 74: Latin America Retinal Disorder Treatment Market Value Share, by Dosage Form, 2018 and 2027
  • Figure 75: Latin America Retinal Disorder Treatment Market Attractiveness, by Dosage Form, 2019-2027
  • Figure 76: Latin America Retinal Disorder Treatment Market Value Share, by Distribution Channel, 2018 and 2027
  • Figure 77: Latin America Retinal Disorder Treatment Market Attractiveness, by Distribution Channel, 2019-2027
  • Figure 78: Middle East & Africa Retinal Disorder Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2027
  • Figure 79: Middle East & Africa Retinal Disorder Treatment Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
  • Figure 80: Middle East & Africa Retinal Disorder Treatment Market Attractiveness, by Country/Sub-region, 2019-2027
  • Figure 81: Middle East & Africa Retinal Disorder Treatment Market Value Share Analysis, by Disease Indication, 2018 and 2027
  • Figure 82: Middle East & Africa Retinal Disorder Treatment Market Attractiveness, by Disease Indication, 2019-2027
  • Figure 83: Middle East & Africa Retinal Disorder Treatment Market Value Share Analysis, by Therapeutic Class, 2018 and 2027
  • Figure 84: Middle East & Africa Retinal Disorder Treatment Market Attractiveness, by Therapeutic Class, 2019-2027
  • Figure 85: Middle East & Africa Retinal Disorder Treatment Market Value Share, by Dosage Form, 2018 and 2027
  • Figure 86: Middle East & Africa Retinal Disorder Treatment Market Attractiveness, by Dosage Form, 2019-2027
  • Figure 87: Middle East & Africa Retinal Disorder Treatment Market Value Share, by Distribution Channel, 2018 and 2027
  • Figure 88: Middle East & Africa Retinal Disorder Treatment Market Attractiveness, by Distribution Channel, 2019-2027